4//SEC Filing
Bolzon Bradley J PhD 4
Accession 0000899243-21-026769
CIK 0001826457other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 5:05 PM ET
Size
19.4 KB
Accession
0000899243-21-026769
Insider Transaction Report
Form 4
Bolzon Bradley J PhD
Director10% Owner
Transactions
- Conversion
Series A convertible preferred stock
2021-06-28−20,004,280→ 0 total(indirect: By Versant Capital VI, L.P.)→ Common Stock (5,666,131 underlying) - Conversion
Series B convertible preferred stock
2021-06-28−3,000,000→ 0 total(indirect: By Versant Capital VI, L.P.)→ Common Stock (849,738 underlying) - Conversion
Common Stock
2021-06-28+1,940,043→ 1,940,043 total(indirect: By Versant Vantage I, L.P.) - Conversion
Common Stock
2021-06-28+6,515,869→ 6,799,115 total(indirect: By Versant Venture Capital VI, L.P.) - Conversion
Series B convertible preferred stock
2021-06-28−4,150,000→ 0 total(indirect: By Versant Vantage I, L.P.)→ Common Stock (1,175,470 underlying) - Conversion
Series C convertible preferred stock
2021-06-28−2,699,328→ 0 total(indirect: By Versant Vantage I, L.P.)→ Common Stock (764,573 underlying) - Purchase
Common Stock
2021-06-28$19.00/sh+157,895$3,000,005→ 2,097,938 total(indirect: By Versant Vantage I, L.P.)
Footnotes (3)
- [F1]Each share of Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a 3.5305-for-one basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date.
- [F2]Shares held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. The Reporting Person is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any.
- [F3]Shares held by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. The Reporting Person is a managing member of Versant Vantage I GP-GP, and may be deemed to share voting and dispositive power over the shares held by Versant Vantage I. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001354345
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 5:05 PM ET
- Size
- 19.4 KB